Antithesis
Antithesis Raises $105 million in Series A
Antithesis Raises $105 million in Series A
Antithesis has successfully raised $105 million in a Series A at a Undisclosed led by Jane Street.
Company Overview
Antithesis is a Enterprise Software company headquartered in Northern Virginia, founded in 2018 with 150+ employees.
Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years.
Fundraising Details
- Amount Raised: $105 million
- Round Type: Series A
- Valuation: Undisclosed
- Date: 2025-12-03
- Investors: Jane Street and Amplify Venture Partners and Spark Capital and Tamarack Global and First In Ventures and Teamworthy Ventures and Hyperion Capital
About Antithesis
Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years. The company is positioned in the Enterprise Software sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Northern Virginia
- Founded: 2018
- Team Size: 150+
- Industry: Enterprise Software
What This Means
This funding round demonstrates strong investor confidence in Antithesis's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Enterprise Software sector continues to attract significant investment as companies innovate to meet evolving market demands. Antithesis's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching Undisclosed marks an important milestone for Antithesis, positioning the company among notable players in the Enterprise Software industry.
Looking Ahead
With this new capital, Antithesis is well-positioned to execute on its growth strategy and continue building innovative solutions in the Enterprise Software space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-12-03. For more information about Antithesis, visit their headquarters at Northern Virginia.
Company Info
Investors (7)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free